ViewsML uses AI for virtual diagnostics, enhancing precision medicine and spatial biology with virtual biomarkers.
ViewsML has raised $4.9M in total funding. The most recent round was Seed. The last funding was announced in April 2026.
ViewsML's investors include Mayo Clinic, Debiopharm Group, RiSC Capital, Wittington Ventures, WUTIF.
ViewsML is headquartered in Vancouver, Canada.
ViewsML uses AI for virtual diagnostics, enhancing precision medicine and spatial biology with virtual biomarkers.
ViewsML is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ViewsML — Funding & Investors." VCBacked, April 20, 2026, https://www.vcbacked.co/company/viewsml. Accessed November 15, 2026.
VCBacked. (2026). ViewsML — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/viewsml
{{cite web |title=ViewsML — Funding & Investors |url=https://www.vcbacked.co/company/viewsml |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at ViewsML? Request a listing update